Related Experiment Video
Updated: Sep 28, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.3K
Fully connected autoencoder and convolutional neural network with attention-based method for inferring
Ping Xuan1, Zhe Gong1, Hui Cui2
1School of Computer Science and Technology, Heilongjiang University, Harbin 150080, China.
Briefings in Bioinformatics
|April 1, 2022
Summary
Identifying disease-associated long noncoding RNAs (lncRNAs) aids disease pathogenesis research. ACLDA, a novel method, effectively predicts disease-related lncRNAs by integrating topology and multi-level features.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Abnormal long noncoding RNA (lncRNA) expression is linked to human diseases, making disease-associated lncRNA identification crucial for understanding pathogenesis.
- Current prediction methods often overlook the intricate topology within meta-paths involving lncRNAs, diseases, and microRNAs (miRNAs).
Purpose of the Study:
- To propose a novel method, ACLDA, for inferring potential disease-related lncRNA candidates.
- To enhance the integration of topological information from heterogeneous networks composed of lncRNA, disease, and miRNA nodes.
Main Methods:
- Constructed a heterogeneous graph integrating lncRNA, disease, and miRNA similarities, associations, and interactions.
- Employed fully connected autoencoders for low-dimensional feature extraction and attention mechanisms for enhanced feature and meta-path learning.
- Utilized convolutional neural networks to encode local topologies from multiple meta-path perspectives.
Main Results:
- ACLDA demonstrated superior performance compared to existing state-of-the-art prediction methods.
- Experimental results confirmed ACLDA's effectiveness in identifying potential disease-related lncRNAs.
- Case studies on breast, lung, and colon cancers validated ACLDA's predictive capabilities.
Conclusions:
- ACLDA offers a powerful approach for discovering disease-associated lncRNAs by effectively integrating complex network topology and multi-level features.
- The method advances the understanding of disease pathogenesis by identifying novel lncRNA-disease associations.
- ACLDA shows significant potential for application in clinical diagnostics and therapeutic target identification.
Related Concept Videos
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Classification of Illness
8.0K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.0K
Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Genome-wide Association Studies-GWAS
14.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.5K
